- Home
- BLX vs LMAT Comparison
BLX vs LMAT Comparison
Compare BLX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLX | LMAT |
|---|---|---|
| Founded | 1977 | 1983 |
| Country | Panama | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1997 | 2006 |
Fundamental Metrics
Financial Performance| Metric | BLX | LMAT |
|---|---|---|
| Price | $55.29 | $80.59 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $105.80 |
| AVG Volume (30 Days) | 133.4K | ★ 272.0K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.13% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $18.36 | $14.21 |
| Revenue Next Year | $9.95 | $8.88 |
| P/E Ratio | ★ $8.26 | $55.96 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $38.41 | $78.27 |
| 52 Week High | $63.20 | $118.01 |
Technical Indicators
Market Signals| Indicator | BLX | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 36.84 |
| Support Level | $53.93 | $78.77 |
| Resistance Level | $55.30 | $88.08 |
| Average True Range (ATR) | 1.01 | 1.92 |
| MACD | 0.27 | 0.52 |
| Stochastic Oscillator | 61.44 | 29.17 |
Price Performance
Historical ComparisonAbout BLX Banco Latinoamericano de Comercio Exterior S.A.
Bladex Inc is a Panama-based bank focused on providing financial solutions to financial institutions and corporations throughout Panama.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.